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Abstract
Background: In many countries, substitution of physicians by nurses has become common due to the shortage of
physicians and the need for high-quality, affordable care, especially for chronic and multi-morbid patients. We
examined the evidence on the clinical effectiveness and care costs of physician-nurse substitution in primary care.
Methods: We systematically searched OVID Medline and Embase, The Cochrane Library and CINAHL, up to August
2012; selected and critically appraised published randomised controlled trials (RCTs) that compared nurse-led care
with care by primary care physicians on patient satisfaction, Quality of Life (QoL), hospital admission, mortality and
costs of healthcare. We assessed the individual study risk of bias, calculated the study-specific and pooled relative
risks (RR) or standardised mean differences (SMD); and performed fixed-effects meta-analyses.
Results: 24 RCTs (38,974 participants) and 2 economic studies met the inclusion criteria. Pooled analyses showed
higher overall scores of patient satisfaction with nurse-led care (SMD 0.18, 95% CI 0.13 to 0.23), in RCTs of single
contact or urgent care, short (less than 6 months) follow-up episodes and in small trials (N ≤ 200). Nurse-led care
was effective at reducing the overall risk of hospital admission (RR 0.76, 95% CI 0.64 to 0.91), mortality (RR 0.89, 95%
CI 0.84 to 0.96), in RCTs of on-going or non-urgent care, longer (at least 12 months) follow-up episodes and in
larger (N > 200) RCTs. Higher quality RCTs (with better allocation concealment and less attrition) showed higher
rates of hospital admissions and mortality with nurse-led care albeit less or not significant. The results seemed more
consistent across nurse practitioners than with registered or licensed nurses. The effects of nurse-led care on QoL
and costs were difficult to interpret due to heterogeneous outcome reporting, valuation of resources and the small
number of studies.
Conclusions: The available evidence continues to be limited by the quality of the research considered. Nurse-led
care seems to have a positive effect on patient satisfaction, hospital admission and mortality. This important finding
should be confirmed and the determinants of this effect should be assessed in further, larger and more methodically
rigorous research.
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Background
Concerns about the global shortage of health care pro-
viders [1,2] continue to fuel the debate about the need to
introduce new strategies of health care delivery. Especially,
the increasing shortage of physicians makes substitution
by nurses a common demand which is expected to escal-
ate with ageing populations and an increasing prevalence
of chronic conditions. Two systematic reviews published
ten years ago suggested that care provided by nurses
might be equally good as the care provided by physicians
[3,4]. Health outcomes, use of resources and healthcare
costs were found to be similar between nurses and physi-
cians while patient satisfaction was similar or better with
nurse-led care. These differences, however, were limited
by the low volume and quality of the studies. In this con-
text, it is also important to consider that nurses’ education
continues to evolve resulting in different roles and qualifi-
cations across different health care systems. It seems
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timely therefore to assess whether the updated evidence
would support the notion that nurses can substitute physi-
cians in specific clinical tasks. Therefore, we performed a
systematic review and meta-analysis of trials investigating
the clinical effectiveness and costs of nurses working as
substitutes for physicians in primary care.
Methods
We followed a protocol developed prior to starting
the review and followed the PRISMA guidelines [5]
for the reporting of systematic reviews and meta-analyses
(Additional file 1: Table S1).
Study inclusion/exclusion criteria
We included peer reviewed randomised controlled trials
(RCTs) from any country published in English in which
nurses (in any type of role) substituted physicians by
acting as the main figure of care with autonomous or
delegated clinical responsibility for tasks that would have
formerly been performed by physicians alone: where
nurse-led care was compared to physician-led care (family
physicians, paediatricians, and geriatricians); the interven-
tion had taken place in general practices, community or
ambulatory care settings; in patients of all ages seeking
care for all conditions including mental health and ad-
diction restricted to primary care; and which reported
on patient satisfaction, quality of life (QoL), hospital
admission, mortality and cost of health services. Fol-
lowing the framework published in a Cochrane review
[3], we excluded studies in which nurses firstly, pro-
vided services which supplemented or extended the
care provided by physicians or tasks that are not part of
the usual care of physicians and secondly, where nurses
collaborated with other clinicians in a team and thus
the effect of nurse-led care, as the main intervention,
could not be distinguished.
Study identification
We searched OVID Medline, Embase, CINAHL and The
Cochrane Library of Systematic Reviews which includes
the Cochrane Effective Practice and Organisation of
Care Group, from all available dates until August 2012.
The searches, not age-, date- or country-specific in-
cluded ‘primary care’ , ‘skill-mix’, ‘physicians’-‘nurse’ sub-
stitution’ (Additional file 1: Table S2). We also manually
searched the reference lists of included studies and rele-
vant reviews.
Assessment of study quality
We assessed the risk of bias of all trials without the calcu-
lation of a composite score following available guidelines
[6-8]. We considered bias due to attrition of more than
20% to be of significant concern; and adequate intention-
to-treat (ITT) if trial authors analysed participants based
on their original group allocation regardless of protocol vi-
olations or non-compliance [9].
Data extraction
Both qualitative (characteristics of studies, population and
interventions) and numeric data (dichotomous and con-
tinuous format) were extracted using structured data col-
lection forms, designed and pilot-tested a-priori. If more
than one comparison group of interest were reported,
these were combined and compared as one to nurse-led
care. If the results from a single study were reported in
more than one publication, data were extracted as one
study. When one publication reported more than one co-
hort, data were extracted as separate studies.
Selection and assessment of studies and acquisition of data
Two authors independently screened titles and abstracts,
assessed both the full-text of eligible publications and
the risk of bias of included studies, and extracted data.
Differences were resolved through consensus.
Statistical analyses
We calculated the individual and pooled unadjusted
relative risks (RR) and the standardised mean differences
(SMD); and performed meta-analyses when at least three
trials reported appropriate data, using the inverse vari-
ance fixed-effects (FE) method and repeated the analyses
using a random-effects (RE) model in Cochrane RevMan
(Version 5.1) [10]. We report the summary statistics,
their 95% confidence intervals (CI) and consider p < 0.05
statistically significant. When scales pointed in opposite
directions, we subtracted the mean from the maximum
possible value of the scale and estimated the standard de-
viations (SD) using well-established techniques [11]. We
analysed dichotomous and continuous data together by
converting ORs to an effect size expressed in SMD using
available methods [12]. We decided to use a FE model in
keeping with: 1) having no basis to assume that the effects
had a normal distribution, 2) the small number of studies
in at least two of the analyses, 3) the accuracy in estimates
and CIs that FE provides even in a small number of stud-
ies and the more weight assigned to larger studies; RE
gives similar weight to small and larger studies. We quan-
tified heterogeneity using the I2 statistic [13] and explored
the effects of nurse-led care and potential sources of
I2 by pooling data into pre-specified subgroup analyses
by clinical characteristics: nurses’ roles (based on re-
ported details: nurse practitioner with higher degree
courses/specialisation (NP+) versus nurse practitioner
(NP) versus registered/licensed nurse (RN/LN), type of
care (single contact versus on-going care; urgent versus
non-urgent) and length of follow-up (months: <6 ver-
sus ≥6; <12 versus ≥12). We explored the effect of po-
tential sources of bias by study size (small, N < 200 versus
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large, N ≥ 200), allocation concealment (adequate versus
inadequate/unclear) and attrition (<20% versus ≥20%),
and inspected publication bias using funnel plots
where there were at least 10 trials [14]. We performed
sensitivity analyses by excluding trials with potentially
contaminated samples (i.e. patient crossover between
groups), quasi and cluster design and in which nurses
had full clinical autonomy (to perform tasks) and/or
where this information was not reported. For data not
combined in meta-analyses, individual trial estimates
were compared.
Results
Study identification
A total of 4,133 original records were identified. We ex-
cluded 12 of 44 relevant publications for the reasons
provided in Table S3 (Additional file 1). Twenty-six
studies reported in 32 publications met the inclusion cri-
teria and comprised a total of 38,974 randomised partici-
pants (Figure 1) [15-46]. Twenty-four of the studies
were RCTs and the other two were economic evalua-
tions based on three of the appraised RCTs [17,26,38].
Table 1 and Table S4 (Additional file 1) report the sum-
mary and detailed characteristics of participants, inter-
ventions and outcomes of the trials included in review.
Study and population characteristics
There were twenty RCTs of parallel design, three
cluster-RCTs, one quasi-RCT and two studies [31,38]
with cost data from three of the included RCTs
[17,26,39]. The trials were conducted in the UK (n = 9),
the Netherlands (n = 6), the USA (n = 6), Russia (n = 1)
and South Africa (n = 2). Median follow-up was 14.8
(range: 0.5 to 122.4) months with at least 12 months in
fourteen trials, less than 6 months in seven and 6 to 12
months in the other three. The median number of partici-
pants was 1,624 (range: 50 to 12,894) with less than 200 in
eleven trials and more than 200 in the other thirteen. Mean
age was reported in twenty trials and ranged from 10 to 83
years. Twenty-two trials reported on gender and 38.3% of
the participants were male; one included women only.
Settings and interventions
A summary of settings, interventions and nurses’ roles are
reported in Table 1 and Table S5 (Additional file 1). Nurses
worked as physician substitutes in a range of care settings.
The interventions were carried-out in general practices
[17,18,26,29,30,33,39,44], nurse clinics [23,36,40,42] and in
hospital-based, health care centres, specialised practices,
community or university clinics [15,16,22,25,27,28,32,
34,35,37,46]. In the controlled intervention, nurses were the
main figure of care with autonomous or delegated responsi-
bility in various clinical domains including a whole range of
possible (undifferentiated/minor acute/common) or specific
conditions (e.g. hypertension, heart failure, diabetes, HIV,
etc.). In one trial, the clinical domain was assumed to repre-
sent undifferentiated care [35]. Nurses’ specific qualifica-
tions and training were not reported in sufficient detail but
using the information provided by study authors we
grouped nurses’ roles. Nurses’ roles were described in
some detail in sixteen trials (two reported in one publica-
tion) [15-18,22,23,27-29,32,36,37,39,42,46]. Seven trials
employed NP+ only [16,25,28,32,39,40,42], six employed
NPs [18,22,26,30,34,44], eight employed RN and/or LN
[15,23,27,29,33,35-37], one employed NP and NP+ [17],
and one employed NP and LN [46]. Nurses’ interventions
were guideline- or protocol-based in eighteen trials, while
six had no report of having followed specific guidelines.
Nurses’ clinical autonomy was obtainable from twenty-two
trials. In three, nurses had full clinical autonomy to manage
patients with diabetes type II [30] or undifferentiated condi-
tions [34,35]. In the other nineteen, nurses made independ-
ent decisions to perform several tasks (e.g. adopting,
initiating and prescribing treatment, ordering tests or refer-
rals) but they still required minor support or contact with
the physicians (e.g. to sign prescriptions, referrals and tests,
to discuss patients’ records or to develop action plans). Al-
though the interventions in the control group were not
clearly described in at least a few trials, these were assumed
to represent physicians-usual-led care. Ten trials addressed
single contact care [15,39], single contact and on-going care
[27,35,37], single contact and urgent care [17,18,26,34] and
single, on-going and urgent care [22]. The other fourteen
included patients in on-going care for complex conditions
(e.g. HIV, Asthma, hypertension, heart failure, etc.).
Risk of bias in the methods of the included studies
The overall quality of the studies varied substantially
when assessed against current reporting standards [6,11]
(Table 2). Only 54.3% of the trials measured the success
of the intervention by defining a primary outcome. Ran-
dom sequence generation was adequate in 54.0%, alloca-
tion concealment in 42.0%, blinding of patients and
providers in 4% and blinding of outcome assessors in
21.0%. Patient or clinician crossover between groups was
reported in 12.5% of the trials. At baseline, groups were
comparable for all tested factors in 70.8% of the trials.
Both inclusion and exclusion criteria were reported in
70.8%. Sample size calculation based on power (80.0% to
90.0%) was performed in 70.8%, but only ten trials held
the least target sample size to achieve power in at least
one outcome. Rates of missing data varied widely (range:
5.0% to 65.5%). While three did not report any attrition,
more than half (13/24) of the trials had an attrition rate
of at least 20%: nine had more than 20% in both arms in
at least one outcome (range: 10.0 to 65.5%), three had at
least 45.0% per arm, and four had more than 20% (range:
8.0 to 30.0%) in one arm with a differential rate of 9.0%
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to 15.0% across the treatment and control groups. Only
29.2% of the trials reported the use of intention to treat
(ITT) techniques (type not always reported) to deal with
missing data.
Effectiveness of interventions
Patient satisfaction with quality of care
Patient satisfaction questionnaires were either validated
[18,22,26,30], developed for the study purpose [15] or
had unclear validation [17,23,37,39]. Meta-analysis of
seven studies showed a significant increase in the mean
satisfaction scores with nurse-led care (SMD 0.18, 95%
CI 0.13 to 0.23) and significant heterogeneity between
trials (I2 = 91%; χ26df = 65.97; p < 0.00001) (Figure 2).
Subgroup analyses by clinical characteristics showed that
RN had a stronger effect than NPs in increasing patient
satisfaction, although the pooled CIs became wider due
to both the smaller number of studies and smaller sam-
ple sizes (SMD 1.37, 95% CI 0.88 to 1.85). The effect es-
timate also increased in studies of single contact care,
urgent care visits and shorter (less than 6 months)
follow-up episodes, but the significance of the findings
did not change. On the other hand, the effect disap-
peared in studies of on-going care, non-urgent care visits
and longer (greater than 6 months) follow-up episodes.
Subgroup analyses by study quality showed a more mod-
est estimate with the same level of significance in larger
trials, which are less prone to small study bias (N ≥ 200:
Figure 1 PRISMA Flow Diagram - study selection process.
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Table 1 Summary characteristics of participants and interventions of studies included in review
Study Setting Participants Nurses’ group Physicians’ group Intervention Outcomes reported
Location, first
author, year
Design,
period*
FUP,
m
Facilities, n Included diagnosis Nurses,
n
Patients,
N
Mean
age
(SD), y
Male,
%
Phys.,
n
Patients,
N
Mean
age (SD),
y
Male,
%
Nurses’ training/
experience
FCA GDL PS QoL HA M C
ZA 2 cRCT,
2008-
2010.
18 Nurse ART
clinic, 31.
HIV/AIDS. 103 6415 38 (8.9) 30 nr 6479 38 (9.63) 27 Middle nurse
managers trained
to assume
responsibility for
ART and
established
patients’ eligibility
for ART.
no yes ✓ ✓
Fairall, 2012
[36], cohort 2
ZA 1 cRCT,
2008-
2010.
16-18 Nurse ART
clinic, 31.
HIV/AIDS. 103 6159 36 (9.6) 33 nr 4923 35 (9.63) 31 Middle nurse
managers trained
to assume
responsibility for
ART and
established
patients’ eligibility
for ART.
no yes ✓ ✓
Fairall, 2012
[36], cohort 1
NL 6 RCT,
period
nr.
14 Practice, 1. Diabetes Mellitus
Type II.
2 116 67.1
(11)
53 5 114 69.5
(10.6)
42 Practice nurse
with one week
training in
diabetes mellitus;
nurse had no
special training in
the treatment of
diabetes prior to
starting trial.
yes yes ✓ ✓
Houweling,
2011 [30]
NL 5 RCT,
2006-
2008.
24 Hospital
outpatients,
1; Practice,
18.
Asthma. nr 36 11.2
(2.9)
64 nr 71 (37§,
34‡)
11.2 (2.5)
§; 10.1
(2.6)‡
58 Asthma nurse. no yes ✓ ✓
Kuethe, 2011
[25]
RU 1 RCT,
2006
-2009.
6, 18 Medical
centre
practice, 1.
Heart Failure with
Preserved Ejection
Fracture.
10 50 66.5
(3.2)
27 8 50 68 (4.3) 34 Nurses with
special degree in
patient education
obtained in a joint
course.
no yes
✓ ✓ ✓Andryukhin,
2010 [46]
NL 4 RCT,
2006-
2007.
12 Healthcare
centre, 6.
CVD, Hypertension,
Hypercholesterolemia.
6 808 64 (9.0) 58 25 818 64 (9.0) 62 Advance practice
nurse already
employed to
manage patients
with asthma,
chronic
obstructive
pulmonary
disease, or
diabetes.
nr yes ✓
Voogdt-Pruis,
2010 [16]
NL 3 RCT,
2006.
0.5 Practice, 15;
Reference, 5
Common complaints. 12 817 42.8
(16.5)
38 50/17† 684 46.1
(16.6)
40 Nurse practitioner
with Master
no yes ✓ ✓ ✓
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Table 1 Summary characteristics of participants and interventions of studies included in review (Continued)
degree in Advance
Nursing trained in
common
complaints.
Dierick-Van
Dale, 2009 [39]
UK 9 RCT,
2002-
2004.
6 Nurse clinic,
1
GORD, moderate
Gastritis.
nr 89 50.2
(13.9)
49 nr 86 48.4
(12.8)
49 Gastrointestinal
nurse practitioner.
no yes ✓ ✓
Chan, 2009
[42]
NL 2 cRCT,
period
nr.
12 nr. All forms of
incontinence.
1 38 51
(13.0)
0 28¶ 13 51 (13.0) 0 Registered nurse
specialist in
incontinence.
no yes ✓ ✓
Du Moulin,
2007 [37]
US 6 RCT,
period
nr.
6 Community,
2; PHD, 1.
Diabetes Mellitus. nr 95 55.7
(13.1)
32 108# 102 57 (11.4) 35 Diabetes nurse. no yes ✓
Hiss, 2007 [32]
NL 1 RCT,
2000-
2001.
24 Practice, 12 Asthma and COPD. 2 139 49.9
(14.2)
35 14 137 44.7
(13.6)
28 GP assistant with
pre- and during-
trial training to
deal with the dif-
ferences between
asthma and COPD.
no yes ✓
Hesselink, 2004
[33]
UK 8 RCT,
2000-
2001.
6 Nurse clinic
hospital
based.
Diabetes Mellitus
Type II pre-diagnosed
with Hypertension or
in receipt of BPLT.
nr 60 58.1
(13.8)
57 nr 60 62.4 (9.1) 70 Hypertension
nurse.
no yes ✓
Denver, 2003
[40]
UK 7 RCT,
1996-
1999.
24 Practice, 438. Parkinson's Disease. 9 1041 nr 57 nr 818 nr 56 Community nurse
with a course in
Parkinson Disease.
no nr ✓ ✓ ✓
Jarman, 2002
[29]
UK 6 RCT,
period
nr.
4 Health
Centre
Practice, 1
Asthma nr 55 Median
(IQR): 35
(29-47)
56 9 46 Median
(IQR): 37
(27-50)
33 Nurse with
structured training
in Asthma care.
no yes ✓
Kernick, 2002
[27]
US 5 RCT,
1995-
1997.
6-12,
24
Community
clinic, 4;
Primary care
clinic, 1.
Asthma, Diabetes
Mellitus,
Hypertension, or
urgent visits.
7 1181 44 24 11 800 44.9 22 Community nurse
practitioner.
no nr ✓ ✓ ✓
Mundinger,
2000 [22,24]
UK 5 Kernick,
2000 [28]
RCT,
period
nr.
4 Health
Centre, 1
Psoriasis and Eczema. 1 55 47.4
(18.4)
39 nr 54 51.7
(15.8)
48 Practice nurse
with training in
psoriasis and
eczema
management.
no yes ✓
UK 4 RCT,
period
nr
0.5-1 Practice, 10 Diverse complaints. 12 1465║ range: 0
to >75
39 10 1465║ range:
0->75
42 Nurse practitioner
with diploma on
care for same day
consultations for
primary care.
no nr ✓
Kinnersley,
2000 [26]
UK 3 RCT,
period
nr.
0.5 Practice, 20 Diverse complaints:
e.g. minor injuries,
20 (1
per
practice)
651 nr 42 nr 665 nr 43 Nurse with course
at BSc or MSc
level.
no nr ✓ ✓ ✓
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Table 1 Summary characteristics of participants and interventions of studies included in review (Continued)
respiratory
complaints.
Venning, 2000
[17]
UK 2 RCT,
1998-
1999.
0.5 Practice, 5 Acute minor illnesses. 5 900 median
(IQR):26
(9-41.8)
40 19 915 median
(IQR):29.1
(9.7-44.9)
40 Practice nurse
with a course in
minor illnesses
and piloted before
study.
no nr ✓
Shum, 2000
[18]
US 4 qRCT,
1999-
2001.
12 Primary care
veterans
affair clinic,
1
Undifferentiated
conditions.
9 150 62 99 45 300 61 98 Nurse practitioner
who was on staff
for at least six
months in primary
care.
yes yes ✓ ✓
Hemani, 1999
[34]
UK 1 RCT,
1995-
1996.
12,
24,
56.4,
122.4
Practice, 19 Coronary Heart
Disease secondary
prevention.
28 673 66.1
(8.2)
58 nr 670 66.3 (8.2) 58 District and
practice nurses
trained in clinic
protocols/GDLs for
behavioural
techniques
change.
no yes ✓ ✓ ✓ ✓
Campbell, 1998
[19-21,41,43-45]
US 3 RCT,
1980.
0.5 Community
clinic, 1
Family planning,
venereal diseases,
acute non-traumatic
minor illnesses.
5 25 nr nr 5 25 nr nr Registered
professional nurse
with preparation
and skills in
physical diagnosis,
psychosocial
assessment, and
health-illness man-
agement in pri-
mary care.
nr yes ✓
Winter, 1981
[15]
US 2 RCT,
1971.
≥6 HO clinic, 1;
Private, 3
Undifferentiated. 4 40 nr nr nr 20 nr nr Nurse clinicians
with training in
service delivery.
yes nr ✓
Flynn, 1974
[35]
US 1 RCT,
period
nr.
12 University
Hospital
clinic, 1;
Nurse clinic,
1
Hypertension, CVD,
Obesity, Arthritis,
Somatization.
nr 33 range:
16-78
12 nr 33 range:
16-83
12 Nurses who
provided primary
source care for at
least one year
before the study.
no yes ✓ ✓ ✓ ✓
Lewis, 1967
[23]
Legend.
Studies are listed by year (y) of publication, in decreasing order; and labelled after the country where they were conducted.
US, United States; NL, The Netherlands; UK, United Kingdom; ZA, South Africa; RU, Russia; RCT, Randomised Controlled Trial; cRCT, cluster Randomised Controlled Trial; qRCT, quasi-Randomised Controlled Trial; FUP,
follow-up episodes are reported in months (m); nr, not reported; ART, Antiretroviral Therapy; PHD, public health department; HO, Hospital Outpatients; HIV, Human Immunodeficiency Virus; CVD, Cardiovascular Disease;
GORD, Gastro-Oesophageal Reflux Disease; COPD, Chronic Obstructive Pulmonary Disease; BPLT, Blood Pressure Lowering Treatment; SD, standard deviation; IQR, Interquartile Ranges;
FCA, full clinical autonomy; GDL, interventions based on clinical guidelines or protocols; PS, patient satisfaction; QoL, quality of life; HA, hospital admissions; M, mortality; C, costs.
*Start and end year when studies were conducted.
†Reference practices for comparison on economic/cost data.
‡Paediatricians.
§General physicians.
║Number of randomized patients per group not reported.
¶Nine were physicians and nineteen were supervisors.
#Sixty-three were for the control group.
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Table 2 Quality of methods in the studies included in review
Study details (country,
design, funding)
Inclusion &
exclusion criteria
Outcome Sequence
generation
Allocation
concealment
Blinding Sample
size
Attrition
%
Funding
1ry 2ry
ZA 2 ✓ ✓ ✓ A A NP‡ ✓║ ≥20# G
Fairall, 2012 [36] (Cohort 2)
ZA 1 ✓† ✓ ✓ A A NP‡ ✓║ ≥20# G
Fairall, 2012 [36] (Cohort 1)
NL 6 ✓† ✓ ✓ I A NP ✓ <20 G
Houweling, 2011 [30]
NL 5 ✓† ✓ A A NP ✓¶ <20 NR
Kuethe, 2011 [25]
RU 1 ✓ U I ‡ ✓¶ ≥20 None
Andryukhin, 2010 [46]
NL 4 ✓ ✓ A U I‡,§ ✓ <20 P/Ind.
Voogdt-Pruis, 2010 [16]
NL 3 ✓† A A NP NP ≥20 G
Dierick-Van Dale, 2009 [39]
UK 9 ✓† A A NP§ ✓ <20# NR
Chan, 2009 [42]
NL 2 ✓† ✓ ✓ U U NP ✓║ ≥20 NR
Du Moulin, 2007 [37]
USA 6 * U U NP NP <20 G
Hiss, 2007 [32]
NL 1 * ✓ ✓ U U NP§ ✓║ ≥20 NR
Hesselink, 2004 [33]
UK 8 * ✓ ✓ I I NP ✓¶ <20# NR
Denver, 2003 [40]
UK 7 ✓ ✓ ✓ A A NP ✓ <20 P/Ind.
Jarman, 2002 [29]
UK 6 *† ✓ ✓ A U U ✓ ≥20# NR
Kernick, 2002 [27]
US 5 * U U NP ✓¶ ≥20 G
Mundinger, 2000 [22,24]
UK 5 ✓ ✓ A U U ✓¶ ≥20 Ind.
Kernick, 2000 [28]
UK 4 ✓ ✓ ✓ A A NP ✓║,¶ ≥20 G
Kinnersley, 2000 [26]
UK 3 ✓ A A NP NR║,¶ ≥20 P
Venning, 2000 [17]
UK 2 ✓ A A NP ✓¶ ≥20 G
Shum, 2000 [18]
US 4 ✓ I I NP NP U NR
Hemani, 1999 [34]
UK 1 ✓ A I NP§ ✓ ≥20# G
Campbell, 1998 [19-21,41,43-45]
US 3 ✓ ✓ U U A‡ NR U NR
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Table 2 Quality of methods in the studies included in review (Continued)
Winter, 1981 [15]
US 2 * U U NP NR <20 NR
Flynn, 1974 [35]
US 1 * U U NP§ NR U# G
Lewis, 1967 [23]
Legend.
Studies are listed by year (y) of publication, in decreasing order. Blinding: whether patients, care providers and outcome assessors were blinded. Attrition of more
than 20% is of significant concern. Intention to treat (ITT) whether study authors analysed all patients based on their original group allocation regardless of
protocol violations or non-compliance. US, United States; NL, The Netherlands; UK, United Kingdom; ZA, South Africa; RU, Russia; I, Inadequate; A: Adequate;
U, Unclear; NP, Not Performed; NR, Not reported; Funding, Government (G), Industry (Ind.) or Private (P) grant.
*Only the inclusion criteria was reported.
†Not all factors tested at baseline were comparable between groups.
‡Fairall et al. (2012) [36] partly blinded data analysts; Andryukhin et al. (2010) [46] blinded clinicians not patients; Voogdt-Pruis et al. (2010) [16] blinded patients
not clinicians; Winter (1981) [15] blinded patients and clinicians.
§Outcome assessors blinded for some or all outcomes.
║Used a cluster effect approach (e.g. Huber-White).
¶Reached the least target sample required to achieve power.
#Used ITT strategies to deal with missing data.
Figure 2 Effects of physician-nurse substitution on patient satisfaction in A) all trials and by B) subgroups. Legend. CI, confidence
interval; df, degrees of freedom; N, total number of patients; SMD, standard mean differences; SD, standard deviation; Chi2, statistical test for
heterogeneity; P, p-value of Chi2 (evidence of heterogeneity of intervention effects); I2, amount of heterogeneity between trials; Overall P, p-value
for significance of effects of interventions; NLC, Nurse-Led Care; PLC, Physician-Led Care; NP, Nurse Practitioner; NP+, Nurse Practitioner with
higher degree/courses/specialisation; RN, Registered Nurse. *All trials had ≥20% attrition in at least one arm.
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SMD 0.16, 95% CI 0.11 to 0.22; N < 200: SMD 1.37, 95%
CI 0.88 to 1.85). The effect was not significant in trials
with inadequate allocation concealment. All trials had at
least 20% attrition. Heterogeneity disappeared in the sub-
group of registered nurses and smaller trials (N < 200).
Two other trials with qualitative data reported signifi-
cantly higher patient satisfaction scores with nurse-led
care [23,30].
Hospital admissions
Five trials had sufficient data for meta-analysis (Figure 3),
two of which reported different follow-up episodes
[22,46]. The pooled RR showed a significant reduction
in the risk of all-cause hospital admissions with nurse-
led care (RRs 0.76, 95% CI 0.64 to 0.91) and no signifi-
cant heterogeneity between trials (I2 = 7%; χ23df = 4.30;
p = 0.37). Subgroup analyses by clinical characteristics
showed that NPs had a positive effect in reducing all-
cause admissions to hospital (RRs 0.74, 95% CI 0.62 to
0.89) while the effect was not significant with RNs. The
estimate increased in studies of on-going care, non-
urgent visits and longer (at least 12 months) follow-up
episodes. The effect disappeared in trials of single con-
tact care, urgent care and shorter (less than 12 months)
follow-up episodes. Subgroup analyses by study quality
showed that in large trials (less prone to bias) nurse-led
care had an increasingly significant effect in reducing
hospital admissions (N < 200: RR 1.09, 95% CI 0.54 to
2.17; N ≥ 200: RR 0.74, 95% CI 0.62 to 0.89). However,
trials that were of higher quality in other ways (e.g. better
allocation concealment and less attrition) tend to show
the opposite effect with better quality being associated
with higher rates of admissions with nurse-led care, albeit
non-significant. Heterogeneity remained non-significant
across subgroups and disappeared in studies of nurse
practitioners, on-going and urgent care, longer follow-up
episodes, larger trials and trials with at least 20% attrition.
In addition, data that were not pooled showed less
Figure 3 Effects of physician-nurse substitution on hospital admissions in A) all trials and by B) subgroups. Legend. CI, confidence
interval; df, degrees of freedom; N, number of patients with events; Total, total number of patients per group; RR, Relative Risk; Chi2, statistical test
for heterogeneity; P, p-value of Chi2 (evidence of heterogeneity of intervention effects); I2, amount of heterogeneity between trials; Overall P,
p-value for significance of effects of interventions; NLC, Nurse-Led Care; PLC, Physician-Led Care; NP, Nurse Practitioner; NP+, Nurse Practitioner
with higher degree/courses/specialisation; RN, Registered Nurse. *Two RCTs provided data for different follow-up episodes and were incorporated
accordingly: Andryukhin et al. (2010) [46] reported data at 6 and 18 months and Mundinger et al. (2000) [22,24] reported data at 6 and 12 months.
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hospital admissions with nurse-led care [23,36] or no
significant differences between groups [22,44,36] (see
Additional file 1: Table S7). Qualitative data reported less
hospital admissions with nurse-led care at 24 months [25]
or no significant differences between groups at 1 month
[26] or 12 months [34].
Mortality
Ten trials had sufficient data for meta-analysis, one of
which reported different follow-up episodes [46] (Figure 4).
The pooled RRs showed a significant reduction in the risk
of all-cause mortality with nurse-led care (RRs 0.89, 95%
CI 0.84 to 0.96) and no significant heterogeneity between
trials (I2 = 0%; χ29df = 7.52; p = 0.58). Subgroup analyses
by clinical characteristics showed that NPs had an in-
creased effect but less significant than RN/LN in reducing
all-cause mortality (NP: RRs 0.76, 95% CI 0.60 to 0.96;
RN/LN: RRs 0.92, 95% CI 0.85 to 0.98). Although NPs+
showed an increased estimate, the CIs were wide and less
significant (RR 0.19, 95% CI 0.04 to 0.85). The estimate in-
creased in studies of on-going care, non-urgent visits and
longer (at least 12 months) follow-up episodes but the CIs
and significance remained the same. The effect disap-
peared in trials of single contact, urgent care visits (n = 1)
and shorter (less than 12 months) follow-up episodes. The
estimate increased, although with wider CIs and less sig-
nificance, in trials with inadequate allocation concealment
(RRs 0.73, 95% CI 0.58 to 0.91) and in trials with at least
20% attrition (RRs 0.90, 95% CI 0.83 to 0.97). On the other
hand, the estimate decreased, with reduced significance, in
trials of adequate concealment and trials of less than
20% attrition and disappeared in small trials (N < 200,
RR 0.54, 95% CI 0.21 to 1.36). Heterogeneity between
trials remained non-significant in all subgroups
Figure 4 Effects of physician-nurse substitution on mortality in A) all trials and by B) subgroups. Legend. CI, confidence interval; df, degrees of
freedom; N, number of patients with events; Total, total number of patients per group; RR, Relative Risk; Chi2, statistical test for heterogeneity;
P, p-value of Chi2 (evidence of heterogeneity of intervention effects); I2, amount of heterogeneity between trials; Overall P, p-value for significance of
effects of interventions; NLC, Nurse-Led Care; PLC, Physician-Led Care; NP, Nurse Practitioner; NP+, Nurse Practitioner with higher degree/courses/
specialisation; RN, Registered Nurse. *Andryukhin et al. (2010) [46] reported data at 6 and 18 months and was incorporated accordingly.
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although low heterogeneity was introduced in trials with
less than 20% attrition and smaller trials. The funnel
plot was asymmetrical showing five trials falling to the
left (nurse-led care with fewer events), two on the right
and three on the line of no effect. Data that could not
be pooled showed a significantly lower cumulative rate
of all-cause mortality and a marginal significance in the
cumulative rate of mortality due to coronary/non-fatal
myocardial infarction with nurse-led care at 56.4
months [44] (Additional file 1: Table S7). Qualitative
data reported to have no documentation of death after
12 months follow-up [36].
Sensitivity analyses
In the meta-analyses (Figures 2, 3 and 4), excluding the
studies in which nurses had full clinical autonomy or from
which this information was not obtainable did not critically
alter the estimates (Additional file 1: Table S6). The small
non-significant amount of heterogeneity in the meta-
analysis of hospital admissions was attributable to a small
study which favoured physician-led care but had wide CIs.
Excluding quasi-RCTs or cluster RCTs from the meta-
analyses of patient satisfaction and mortality slightly re-
duced the pooled estimate but did not alter the direction of
effects and the findings remained significant.
Random-effects meta-analyses
Meta-analyses using a RE model showed the same direc-
tion of effect. The pooled estimates and heterogeneity
remained significant. Patient satisfaction showed an in-
creased estimate although wider CIs (SMD 0.31, 95% CI
0.12 to 0.514, p = 0.002; I2 = 91%; χ26df = 65.97; p < 0.0001).
Hospital admissions (RRs 0.77, 95% CI 0.63 to 0.94, p =
0.01; I2 = 7%; χ24df = 4.30; p = 0.37) and mortality (RRs 0.90,
95% CI 0.84 to 0.96, p = 0.002; I2 = 0%; χ2 9df = 7.52;
Figure 5 Comparison of individual trial estimates of the effect of physician-nurse substitution on Quality of Life. Legend. A pooled
estimate was not possible due to the various scales used, grading scores and measurements. SMD, standard mean difference; SE, standard error;
N, total number of patients per group; CI, confidence interval; NLC, Nurse-Led Care; PLC, Physician-Led Care.
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p = 0.58) showed very similar estimates of a more mod-
est but yet significant effect.
Quality of life
Four [27-29,37] of the thirteen [17,22,23,27-30,33,37,
39,42,44,46] trials with measures on QoL used both
disease-specific and generic scales of functional health and
well-being. Other seven [17,22,23,30,39,42,44] used only
generic scales and two used only disease-specific scales
[33,46]. Due to the different scales, grading scores and mea-
surements, we decided not to combine trials in a pooled
analysis (Figure 5). Comparison of the individual estimates
of trials using generic scales showed nurse-led care signifi-
cantly improved QoL scores with the SF-12 at 6 months
(SMD 0.70, 95% CI 0.40 to 1.00) and with the Global Gen-
eral Questionnaire for Parkinson’s Disease at 24 months
(SMD 0.16, 95% CI 0.05 to 0.27). Estimates from trials using
the SF-36 and Euroqol did not reach significance although
some favoured nurse-led care. Trial estimates [27,33,46]
using disease-specific scales at 4, 6, 12, and 24 months
favoured nurse-led care but were not significant. Four trials
reported better scores with nurse-led care in various indi-
vidual dimensions of the ARQoL, SF-36 and RIQ question-
naires but the overall score was not significant at two weeks
[45] or not sustained at least 12 month thresholds
[27,33,44] except for patients with incontinence for whom
better scores of individual dimensions at 6 months persisted
at 12 months or reached a significant overall score (re-
ported p < 0.05) [37]. Qualitative data based on generic
scales reported significance (general health questionnaire)
[23] or non-significance (SF-36, EQ5D-VAS) in the overall
score at 0.5 [17] or at 4 [27] months.
Figure 6 Comparison of individual trial estimates of the effect of physician-nurse substitution on cost of care. Legend. A pooled
estimate was not possible due to the variety in approaches, currency and indicators used to value resources and to calculate costs. Abbreviations:
EUR, Euro; GBP, pound sterling; DCC, direct costs for consultations; DPCC, direct and productivity costs for consultations; general physicians (GP);
EMP, employment; EMPO, employment by others; LoC, length of consultations; TCT, total consultation time; TP, time to prescribe; FTF, face-to-
face; TT, total time; SD, standard deviation; N, total number of patients per group; SMD, standard mean difference; CI, confidence interval; NLC,
Nurse-Led Care; PLC, Physician-Led Care. *EUR; DPCC: GPs salary in EMP and EMPO; p = 0.65. †EUR; DCC based on resource use, follow-up, LoC
/salary; p = 0.0005. ‡EUR; DCC: resource use, follow-up, LoC /salary; p = 0.0001. §EUR; all patients: DPCC: GP salary in EMP and EMPO; p = 0.0009.
║EUR; <65 years: DPCC: GP salary in EMP and EMPO; p < 0.0001. ¶GBP; return consultations, FTF time: NP = TCT - TP (GP signed); GP = TCT - TP;
p = 0.11. #GBP; initial consultations, TT: NP = TCT + TP (GP signed); GP = TCT + TP; p = 0.11. **GBP; initial consultations, FTF time: NP = TCT – TP
(GP signed); GP = TCT + TP; p = 0.07. ††GBP; return consultations, TT: NP = TCT – TP (GP signed); GP = TCT + TP; p = 0.16. ‡‡GBP; costs of drugs;
p < 0.0001. §§GBP; mean QALYs at 48 months: SF-36 overall QoL scores; p = 0.0006. ║║EUR; DPCC: resource use, follow-up, LoC and salary; p = 0.09.
¶¶EUR; DC: resource use, follow-up, LoC and salary; p = 0.04. ##EUR; <65 years of age; DPCC: resource use, follow-up, LoC and salary; p = 0.10.
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Costs
There were six trials [17,23,29,35,42,44] with data on cost
and two [31,38] comprehensive economic evaluations.
Due to the large variety of approaches used to value the
resources and calculate cost we didn’t pool trials in a
meta-analysis. Figure 6 shows the comparison of the indi-
vidual trial estimates. Costs were generally lower with
nurse-led care in direct costs including consultations
within study practices, for all patients and in patients not
yet 65 years old, in study practices (compared to external
reference practices) [38] at 0.5 or 12 [23] months, and in
treatment costs with both unadjusted and adjusted data at
6 months [42]. On the other hand, the mean cost per
quality adjusted life years (QALYs) at the end of 56.4
months and the cost of interventions (clinics and drugs)
were significantly higher with nurse-led care in one trial
[44]. Another trial showed lower costs with nurse-led
care based on face-to-face total cost of clinicians (total
consultation time without the time to get prescriptions
signed by physicians or time taken to sign a prescription)
[17]. The studies also showed no significant differences
between nurses and physicians in direct and productivity
costs for consultations in all patients at study practices
[38], direct and productivity costs for consultations in all
patients or for patients not yet 65 years old at study prac-
tices (compared to external reference practices) [38], in
the costs of care based on either the total time or face-to-
face time given by the nurse or physician [17] or other
healthcare system costs (hospitals, outpatient attendances
and admissions to private hospitals) [44].
Other trials reported lower healthcare costs with nurse-
led care at 6 to 56.4 months [23,35,44] and no significant
differences between groups in net healthcare costs [29].
Discussion
Substitution of physicians by nurses is often discussed
and widely practiced in many countries, with the aim of
satisfying the demands of an aging population and
(local) shortages of physicians. Our review showed that
the volume of rigorous evaluations is slowly increasing
but remains low. In addition, the quality of available re-
search does allow strong recommendations for practice
and policy, despite previous proposals [6,7].
In the appraised literature, the nurses assessed a wide
variety of conditions and performed various tasks, with
different degrees of clinical autonomy and in different
settings. Despite this heterogeneity and the substantial
methodological limitations, our review suggested that
nurse-led care is associated with higher patient satisfac-
tion, lowered overall mortality and lowered hospital ad-
missions. Effects on other outcomes, such as QoL and
costs remained inconclusive.
The effect of nurse-led care on hospital admissions
and mortality was particularly present in studies of on-
going care and non-urgent visits and when nurse practi-
tioners (both NP and NP with higher degree/courses)
provided the care. This suggests that trained nurses can
effectively provide healthcare to patients with established
diseases. However, the effect disappeared (for hospital
admissions) or weakened (for mortality) in studies with
better or adequate concealment of allocation and in lar-
ger studies. The reasons for this surprising and import-
ant finding, especially that nurse-led care could lead to
reduced mortality, should be addressed in future studies.
Our overall results also showed a highly significant ef-
fect of nurse-led care on patient satisfaction although
with severe heterogeneity between trials. This finding is
consistent with previous reviews [3,4]. Nevertheless, this
result should be interpreted with caution. Although the
average effect is positive, subgroups of patients reported
less positive views. Our results suggest this variability
may be due to nurses’ roles or study size, which may be
associated with other factors (such as degree of clinical
autonomy). The effect disappeared when we considered
only the trials based on on-going care or non-urgent
care, and in trials with longer follow-up episodes (at
least 6 months), but these subgroups included two trials
only. Surprisingly, patient satisfaction was higher with
general nurses (as compared to NPs or NPs with higher
degree/extra courses), but the two very small studies
showing this effect addressed tasks for very special con-
ditions such as incontinence and family planning. This
finding fits in with previous research which showed that
patients appreciate nurses’ involvement especially in
education and counselling [47,48].
The results on QoL were difficult to interpret due to
heterogeneous reporting of outcomes and the data that
were scattered across different scales with outcome
measurements at variable follow-up time intervals.
Only a few trials used both generic and disease-specific
scales with primarily one trial per scale. There was a
potential increase in QoL scores with nurse-led care,
when health status was evaluated using generic scales,
or for specific conditions (e.g. heart failure, Parkinson’s
Disease) but the effect was not significant or not sus-
tained at length (at least 12 months) or it was contra-
dicted by data from the same studies [28]. Similarly,
there were some effects of lower costs with nurse-led
care, but the reported data used different approaches to
value the resources and to calculate costs in only a few
trials and economic evaluations.
Methodological appraisal of included studies
We identified several significant limitations in the
current evidence which should be considered in future
research. The trials included were highly heterogeneous
in terms of tasks, settings, collection and reporting of
outcome measurements. There is a considerable amount
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of data that are reported in descriptive accounts only,
limiting both their pooled validity and the interpretation
of their results. Additionally, many studies failed to re-
port some important statistical information (e.g. sample
sizes, mean scores, SDs) required to calculate trial esti-
mates and to integrate them in a meta-analysis.
No study fulfilled the set of methodological quality cri-
teria assessed, despite widely available guidelines for RCTs.
Trials of lower methodological quality (small study, at
least 20% attrition and lack/unclear allocation conceal-
ment) tended to inflate the results and only less than 50%
of the trials maintained the least target sample required
to achieve power, which makes results less trustworthy.
The most probable small study bias affecting the effect
sizes are the results of small negative studies which are
generally less likely to be published than small studies with
positive results (i.e. publication bias). Blinding (clinicians,
patients and outcome assessors) was reported in only a
few trials and we don’t rule out the possibility that patient
satisfaction, a subjective outcome, may have been espe-
cially positively affected by this. The trials consisted of
follow-up episodes of variable length (0.5 to 122.4
months) which may have limited the true effect of care es-
pecially in multi-morbid or serious illnesses. Our analyses
partly explained the reasons for heterogeneity where this
was present but several other variables, which we could
not account for, may have also caused this. Patients’ per-
ception and evaluation of satisfaction may be inherently
subjective due to socio-demographic differences, experi-
ences from previous care, the physical environment, and
patient-care provider interactions. Therefore, measure-
ments of outcome using validated tools are preferred. Of
the trials appraised, less than 50% used validated question-
naires for patient satisfaction.
We also identified a lack of trials of cluster randomisa-
tion. Although these may be more complex in design, if
accounted for all key factors including clustering effect,
appropriate sampling and analyses, cluster RCTs could
add important value to the current evidence.
Surprisingly, there is a dearth of economic data. The
little evidence available on the cost of physician-nurse
substitution relies on results which are mainly based on
direct costs and use variable approaches. The more re-
cent literature reports more economic data, but it seems
difficult to integrate these results especially because cost
evaluations differ across countries and thus in cost mea-
surements. We found only two publications [31,38] pro-
viding economic data related to three of the included
trials. Despite continued claims of substituting physi-
cians by nurses based on healthcare costs, the evidence
can only suggest that substitution is cost neutral. There-
fore, as suggested in a recent systematic review of eco-
nomic evaluations [49], to meaningfully place the costs
and consequences of substitution in the context of
healthcare, studies should address all types of costs.
Relevant and appropriate data should be generated by
means of a systematic collection of economic measures,
and specific rules for cost data estimations should also
be defined and followed.
More intensive implementation could enhance the
outcomes of nursing care, but most studies do not pro-
vide the necessary information. In the evaluated studies,
the assumption is that nurses possess the competence
required for substituting physicians, but the level of sub-
stitution does not seem equal among studies. While the
level of training may be a critical factor for an effective
outcome, the studies report incomplete descriptions of
nurses’ roles and competencies. The level of clinical au-
tonomy in nurses does not seem consistent with the
level of training and the tasks performed. Also, nurses
still require support or communication with the phys-
ician for various tasks. It seems then that the level of
qualification and training required to carry out substitu-
tion requires yet a better definition of practice boundar-
ies including a classification of tasks. Better criteria
conceptualised to define nurses’ roles and responsibil-
ities are needed. In addition, the various differences be-
tween countries’ definitions and their organisation of
nurse care should be taken into account. Lastly, more
than half of the evidence reviewed (62.5%) has been con-
ducted in Europe, mainly the UK and the Netherlands.
It is apparent that there is much room for primary
studies that include larger numbers of patients, meth-
odologically more rigorous in terms of quality, compre-
hensive in terms of data and statistical methods and
with longer follow-up episodes. Furthermore, in order to
gain a better understanding of substitution, future re-
search should map a wider range of nurses, the various
levels of training and clinicians’ characteristics, which
are provided in many countries. As suggested previously
[50], each method of skill-mix may have its own
strengths and weaknesses. The implementation of meth-
odologies aiming at the standardisation of skill-mix stud-
ies could support a sound assessment such that health
sector reform may also benefit from the publication of
evidence.
Strengths and limitations of the review
Our review updates and extends earlier systematic re-
views [3,4] and benefits from a thorough assessment of
RCTs, in which the nurse acted as the main figure of
care. It also presents (where available) the results by
nurses’ roles. Having used the fixed effect model, we can
only make inferences about the studies included in the
meta-analyses performed here. We only included RCTs
because these are at a lower risk of bias and allow for
the identification of causal relationships. Although non-
randomised trials may overestimate the benefits of
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nurse-led care it would be recommended to scrutinise
the current evidence with such designs. These may not
only provide an opportunity for an update but also allow
for the collection of data from long term (more than 12
months) follow-up designs which may consist of larger
sample sizes. We only included publications in English.
We did however screen the reference lists of relevant re-
views (some in foreign languages) and searched the ref-
erence lists of all included studies. We did not contact
authors for further information nor did we search for
grey literature. A further limitation is that it was often
difficult to understand in detail what role and responsi-
bilities nurses had, when substituting physicians. In
many cases, they remain embedded in patient care teams
that also involved physicians.
Conclusion
The slowly growing number of studies, assessing substitu-
tion of physicians by nurses is still substantially limited by
methodological deficiencies. Also, the current evidence
belongs to a small selection of healthcare systems lacking
good quality data. Nevertheless, nurse-led care seems to
have a positive effect on hospital admissions and mortal-
ity. This important finding should be confirmed and the
determinants of this effect should be assessed in future
studies. Before implementing new changes in the delivery
of healthcare, further, larger and more methodically rigor-
ous primary research should address the quality of
the data on both health outcomes and costs. Primary
research should also differentiate between types of nurses,
qualifications and tasks. In particular, we recommend con-
sidering the role of multidisciplinary teams in which
nurses are embedded, also when substituting physicians in
specific clinical tasks.
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